Drug Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Drug Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Apoptosis
Ceramide activates a mitochondrial p38 mitogen-activated protein kinase
November 18th, 2005
According to a study from Canada, ceramide activates a mitochondrial p38 mitogen-activated protein kinase (MAPK). "This study examined the impact of ceramide, an intracellular mediator of apoptosis, on the mitochondria to test the hypothesis that ceramide utilized p38 MAPK in the mitochondria to alter mitochondrial potential and induce apoptosis," wrote J.Y. Kong and colleagues, University of British Columbia. "The capacity of ceramide to adversely affect mitochondria was demonstrated by the significant loss of mitochondrial potential (Delta psim ), indicated by a J-aggregate fluorescent probe, after embryonic chick cardiomyocytes were...
Source: Drug Week (2005-11-18)
|